Consort diagram indicating sample sizes at each stage during the study.

<p>Consort diagram indicating sample sizes at each stage during the study.</p

Demographic and Baseline Clinical Characteristics of the 510 patients with mCRC included in the Nordic VII Study with pretreatment plasma YKL-40.

<p>Demographic and Baseline Clinical Characteristics of the 510 patients with mCRC included in the Nordic VII Study with pretreatment plasma YKL-40.</p

Kaplan-Meier curves showing the association between pretreatment plasma YKL-40 and PFS.

<p>For patients with metastatic colorectal cancer included in the NORDIC VII Study. All patients (1A), patients treated in arm A (1B), arm B (1C), and arm C (1D). Patients are dichotomized according to the age-corrected plasma YKL-40 (95 percentile level in healthy subjects). The P-value refers to the log-rank test for equality of strata.</p